Skip to main content
# Title Research Year
121 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer 2015
122 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
123 METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER 2015
124 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. 2015
125 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
126 METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER 2015
127 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. 2015
128 Rate of thyroglossal duct remnant visualization
after total thyroidectomy for differentiated thyroid
carcinoma and its impact on clinical outcome of
radioactive iodine (I‑131) ablation
2015
129 Concurrent Radiochemotherapy in Locally Advanced Head and Neck Cancer: Analysis of Treatment Results and Prognostic factors 2015
130 GDP versus DHAP in relapsed and refractory Hodgkin disease 2015